Drug Trial Radar · NCT07190209
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
942
Planned (sponsor's estimate)
Start
Sep 16, 2025
Primary completion
Nov 27, 2029
Study completion Jan 22, 2030
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- First posted
- Sep 24, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared with placebo in adult participants (aged 40 to 80 years, inclusive) with inadequately controlled Chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype. Participation to the study consists of 3 periods: * Screening period of up to 4 weeks * Randomized intervention period of approximately 48 weeks * Follow-up period: Approximately 8 weeks The study duration will be up to 60 weeks.
Conditions
- Chronic Obstructive Pulmonary Disease
Interventions
LunsekimigDrug
Pharmaceutical form: solution for injection in prefilled syringe. Route of administration: Subcutaneous injection
PlaceboDrug
Pharmaceutical form: solution for injection. Route of administration: Subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized rate of moderate-to-severe chronic obstructive pulmonary disease (COPD) exacerbationsTime frame: From Baseline up to 48 weeks
Locations
322 sites in 25 countries. Site status is shown where the registry gives one.
Chandler Clinical Research Trials- Site Number : 8400025
Chandler, Arizona · Completed
Pulmonary Associates - Phoenix - East Bell Road- Site Number : 8400114
Phoenix, Arizona · Recruiting
Epic Medical Research - Surprise- Site Number : 8400096
Surprise, Arizona · Recruiting
IMAX Clinical Trials- Site Number : 8400109
La Palma, California · Recruiting
Long Beach Research Institute- Site Number : 8400027
Long Beach, California · Recruiting
Downtown L.A. Research Center- Site Number : 8400009
Los Angeles, California · Recruiting
Newport Native MD- Site Number : 8400003
Newport Beach, California · Recruiting
Paradigm Research - Redding- Site Number : 8400108
Redding, California · Recruiting
Amicis Research Center - Valencia- Site Number : 8400119
Valencia, California · Recruiting
Helix Biomedics- Site Number : 8400065
Boynton Beach, Florida · Recruiting
Beautiful Minds Clinical Research Center- Site Number : 8400017
Cutler Bay, Florida · Recruiting
Solution Clinical Research- Site Number : 8400039
Doral, Florida · Completed
Eastern Medical Group Research- Site Number : 8400020
Fort Myers, Florida · Recruiting
Premier Medical Associates- Site Number : 8400012
Lady Lake, Florida · Completed
University of Miami Dermatology Clinical Trials Unit- Site Number : 8400078
Miami, Florida · Recruiting
MCR Research- Site Number : 8400004
Miami, Florida · Recruiting
Nuren Medical & Research Center- Site Number : 8400030
Miami, Florida · Recruiting
My Community Research Center- Site Number : 8400164
Miami, Florida · Recruiting
Reed Medical Research Corp- Site Number : 8400167
Miami, Florida · Recruiting
Deluxe Health Center- Site Number : 8400010
Miami Lakes, Florida · Recruiting
Omega Research Consultants - Orlando - Forest City- Site Number : 8400015
Orlando, Florida · Recruiting
Pharmakon Medical Research- Site Number : 8400156
Palm Beach Gardens, Florida · Recruiting
Broward Research Center - Pembroke Pines- Site Number : 8400053
Pembroke Pines, Florida · Recruiting
Clinical Research Trials of Florida- Site Number : 8400011
Tampa, Florida · Recruiting
Deluxe Health Center-Tampa- Site Number : 8400056
Tampa, Florida · Recruiting
Private Practice - Dr. David Kavtaradze- Site Number : 8400006
Cordele, Georgia · Recruiting
Primeway Clinical Research- Site Number : 8400121
Fayetteville, Georgia · Recruiting
University of Illinois-Chicago - College of Medicine- Site Number : 8400055
Chicago, Illinois · Recruiting
Avicenna Clinical Research- Site Number : 8400126
Chicago Ridge, Illinois · Recruiting
NorthShore Medical Group - Evanston ( Endeavor Health)- Site Number : 8400073
Evanston, Illinois · Recruiting
Indy Clinical Research- Site Number : 8400071
Indianapolis, Indiana · Recruiting
University of Kansas Medical Center- Site Number : 8400054
Kansas City, Kansas · Recruiting
University of Michigan Health System - Ann Arbor- Site Number : 8400090
Ann Arbor, Michigan · Recruiting
Veritas Clinical Research- Site Number : 8400007
Madison Heights, Michigan · Recruiting
Mayo Clinic in Rochester - Minnesota- Site Number : 8400005
Rochester, Minnesota · Recruiting
Henderson Clinical Trials- Site Number : 8400026
Henderson, Nevada · Recruiting
Sanmora Bespoke Clinical Research Solutions- Site Number : 8400144
East Orange, New Jersey · Recruiting
New York Hospital Queens- Site Number : 8400058
Flushing, New York · Recruiting
Duke Asthma, Allergy and Airway Center- Site Number : 8400047
Durham, North Carolina · Recruiting
Advanced Respiratory and Sleep Medicine - Hickory- Site Number : 8400013
Hickory, North Carolina · Recruiting
Showing 40 of 322 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.